What is the Share Price of Alkem Laboratories Ltd?

Alkem Laboratories Ltd share price is ₹6,357.45 As on 16 September, 2024|15:52

Home
>
Stocks
>
Alkem Laboratories Ltd

Alkem Laboratories Ltd

Q: What is the Market Cap of Alkem Laboratories Ltd?

The Market Cap of Alkem Laboratories Ltd is ₹76,118 As on 16 September, 2024|15:52

Q: What is PE Ratio of Alkem Laboratories Ltd?

The P/E ratio of Alkem Laboratories Ltd is 35.5 As on 16 September, 2024|15:52

Q: What is PB Ratio of Alkem Laboratories Ltd?

The PB ratio of Alkem Laboratories Ltd is 7.38 As on 16 September, 2024|15:52

₹ 6,357.45 -8.80 (-0.14%)
Updated on 16-09-2024 3:52 PM

Stock Rating

Pros 4

Cons 5

Option Chain

Price Performance

Day's Low
₹6,325

Day's High
₹6,411.25

₹ 6,357.45

52-w low
₹3,447

52-w high
₹6,439.90

6,357.45

Day's open
₹6,369
Previous close
₹6,366.25
VWAP
₹6,367.12
Lower price band
₹5,729.65
Upper price band
₹7,002.85

Today's Market Action

The last traded share price of Alkem Laboratories Ltd was 6,357.45 down by -0.14% on the NSE. Its last traded stock price on BSE was 6,341.90 down by -0.32%. The total volume of shares on NSE and BSE combined was 48,341 shares. Its total combined turnover was Rs 30.78 crores.

Medium and Long Term Market Action

Alkem Laboratories Ltd hit a 52-week high of 6,439.90 on 13-09-2024 and a 52-week low of 3,447 on 05-10-2023. The stock price of Alkem Laboratories Ltd is up by 12% over the last one month. It is up by 72.76% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 76118
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Alkem Laboratories Ltd?

What is the Market Cap of Alkem Laboratories Ltd?

What is PE Ratio of Alkem Laboratories Ltd?

What is PB Ratio of Alkem Laboratories Ltd?

What is the CAGR of Alkem Laboratories Ltd?

How to Buy Alkem Laboratories Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 80.03% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 77.43 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 142 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(16/09/2024)

Margin of Safety Index: Moderate

100.00%

100.00% People are bullish about Alkem Laboratories Ltd

0.00%

0.00 % People are bearish about Alkem Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %